Comprehensive Market Analysis on Chemiluminescence Immunoassay Market projected to reach USD 19.34 Billion by 2030 | CAGR of 7.8% | Forecast period 2023-2030, published by MarketDigits

Chemiluminescence Immunoassay Market Scope:
Market size value in 2023 - USD 11.43 Billion
Market size value in 2030 - USD 19.34 Billion
CAGR (2023-2030) - 7.8%
Forecast Period - 2023-2030
Segments Covered - Product, Application, End User & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Hoffmann-La Roche AG, Immunodiagnostic Systems, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd.

Download Sample Pages-https://www.marketdigits.com/request/sample/3659

Browse in-depth TOC on "Chemiluminescence Immunoassay Market"
178-Tables
95-Figures
332-Pages

The market for Chemiluminescence Immunoassay Market is dominated by North America.
North America secured the leading market share, and is projected to maintain its dominance throughout the forecast period. This regional stronghold can be attributed to factors such as the well-established healthcare infrastructure, widespread adoption of advanced Chemiluminescence Immunoassay (CLIA) solutions, and a rising incidence of chronic diseases. The U.S., in particular, benefits from enhanced accessibility to innovative CLIA systems, the presence of key industry players like Abbott Laboratories, Beckman Coulter, Inc., DiaSorin, and Roche. These factors collectively contribute to the sustained growth of the CLIA market in North America.
With the highest market share, the United States is a dominant player, driven by a growing population grappling with cardiovascular diseases and other chronic conditions. According to the latest data from the Centers for Disease Control and Prevention (CDC) in February 2022, emergency room visits attributed to coronary artery disease, ischemic heart disease, or a history of myocardial infarction constitute 7.2% of current cases. Additionally, CDC data from January 2022 reveals that there were 432,000 emergency department visits in the previous year where stroke was the primary diagnosis. These statistics underscore the significant healthcare burden posed by cardiovascular issues in the United States, contributing to the nation's leading position in the market.

Ask for Discount- https://www.marketdigits.com/request/discount/3659

Top Key Players Covered in the Report-
Abbott Laboratories, Beckman Coulter Inc., BioMerieux , DiaSorin S.p.A, F. Hoffmann-La Roche AG, Immunodiagnostic Systems, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Ortho Clinical Diagnostics, Randox Laboratories Ltd., Roche Holding AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Sysmex Corporation, Tosoh Corporation and Others

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/3659

Recent Developments-
In May 2023, EUROIMMUN's parent company PerkinElmer's life science and diagnostics business segment, has been rebranded as Revvity.

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.